World's Best Scientists 2026 revealed!
Jeffrey M. Jacobson

Jeffrey M. Jacobson

D-Index & Metrics

Microbiology

D-Index
47
Citations
9339
World Ranking
4766
National Ranking
1840

Jeffrey M. Jacobson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jeffrey M. Jacobson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 134 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jeffrey M. Jacobson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey M. Jacobson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jeffrey M. Jacobson is affiliated with Drexel University in the United States and has contributed to the field of Medicine, with a particular focus on Infectious Diseases and HIV research. Their scholarly output includes extensive work in subfields such as Epidemiology, Virology, Emergency Medicine, and Hepatology.

Their research topics prominently feature HIV/AIDS research and interventions, HIV treatment, and related health complications. Additional areas of study include HIV/AIDS drug development, the intersection of HIV with drug use and sexual risk, Hepatitis C virus research, as well as clinical studies on COVID-19.

Recent notable publications by the scientist include:

  • Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 (2021, JAMA)
  • Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy (2023, Cell Host & Microbe)
  • Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV (2021, Nature Communications)
  • A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption (2020, Proceedings of the National Academy of Sciences)
  • HIV post-treatment controllers have distinct immunological and virological features (2023, Proceedings of the National Academy of Sciences)

Jeffrey M. Jacobson frequently collaborates with several researchers in the field. Prominent co-authors include:

  • Richard D. Moore
  • Heidi M. Crane
  • Sonia Napravnik
  • Michael S. Saag
  • Kenneth H. Mayer

Their research has appeared in various scientific venues, with a significant number of publications in:

  • UNC Libraries
  • AIDS
  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Jacobson's academic work covers a broad range within medicine, contributing to infectious diseases, epidemiology, and virology, among other areas. The diversity of publication venues and collaboration network indicates active involvement in multiple facets of infectious disease research, especially focused on HIV/AIDS and related viral infections.

Best Publications

  • Outcomes of Kidney Transplantation in HIV-Infected Recipients

    Peter G. Stock;Burc Barin;Barbara Murphy;Douglas Hanto

  • Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

    B J Luft;R Hafner;A H Korzun;C Leport

  • Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection

    J M Jacobson;J S Greenspan;J Spritzler;N Ketter

  • Inadequate T follicular cell help impairs B cell immunity during HIV infection

    Rafael A. Cubas;Joseph C. Mudd;Anne Laure Savoye;Matthieu Perreau

  • Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

    Jonathan A. Winston;Leslie A. Bruggeman;Michael D. Ross;Jeffrey Jacobson

  • The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

    Rajesh T. Gandhi;Lu Zheng;Ronald J. Bosch;Ellen S. Chan

  • Antiretroviral Activity of the Anti-CD4 Monoclonal Antibody TNX-355 in Patients Infected with HIV Type 1

    Daniel R. Kuritzkes;Jeffrey Jacobson;William G. Powderly;Eliot Godofsky

  • Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

    Marion G. Peters;Janet Andersen;Patrick Lynch;Tun Liu

  • Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

    Jeffrey M. Jacobson;Israel Lowy;Courtney V. Fletcher;Tobias J. O'Neill

  • Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

    Livio Azzoni;Andrea S. Foulkes;Emmanouil Papasavvas;Angela M. Mexas

  • Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults

    Jeffrey M. Jacobson;Daniel R. Kuritzkes;Eliot Godofsky;Edwin DeJesus

  • Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial

    Lisa R. Metsch;Daniel J. Feaster;Lauren Gooden;Tim Matheson

  • Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection

    Jeffrey M. Jacobson;Lawrence Feinman;Leonard Liebes;Nancy Ostrow

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

    Jeffrey M. Jacobson;Robert J. Israel;Israel Lowy;Nancy A. Ostrow

  • Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults

    Jeffrey M. Jacobson;Michael S. Saag;Melanie A. Thompson;Margaret A. Fischl

  • No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-infected Patients Receiving Antiretroviral Therapy

    Rajesh T. Gandhi;Robert W. Coombs;Ellen S. Chan;Ronald J. Bosch

  • Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation.

    Gabriela Stiegler;Christine Armbruster;Brigitta Vcelar;Heribert Stoiber

  • Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.

    Constantinos Petrovas;Benjamin Chaon;David R. Ambrozak;David A. Price;David A. Price

  • Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

    Jeffrey M. Jacobson;Melanie A. Thompson;Jacob P. Lalezari;Michael S. Saag

  • Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

    Vanessa Pirrone;Nina Thakkar;Jeffrey M. Jacobson;Brian Wigdahl

Frequent Co-Authors

Brian Wigdahl
Brian Wigdahl Drexel University
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Pablo Tebas
Pablo Tebas University of Pennsylvania
Ronald J. Bosch
Ronald J. Bosch Harvard University
William C. Olson
William C. Olson Regeneron (United States)
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Niranjan Y. Sardesai
Niranjan Y. Sardesai University of Pennsylvania
David M. Margolis
David M. Margolis University of North Carolina at Chapel Hill
Paul J. Maddon
Paul J. Maddon Columbia University
David B. Weiner
David B. Weiner The Wistar Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to diverse career paths, many of which can be pursued through related online degrees. For individuals with unique challenges, such as those seeking degrees felons can get, online programs provide valuable opportunities to advance education and improve employability in the healthcare and science fields.

One promising avenue involves specialized healthcare roles like becoming a functional medicine nurse practitioner. This career combines clinical expertise with holistic patient care and often requires focused online training. It is an excellent choice for microbiology graduates interested in patient-centered healthcare.

Another fast-growing field linked to microbiology is health information management. Pursuing a bachelor of science in health information management can lead to rewarding positions managing medical data, blending biology knowledge with information technology skills. Salaries in this area are competitive, reflecting the importance of accurate health data management.

For those focused on administrative and coding aspects of healthcare, becoming a certified professional coder is a lucrative option. The cpc medical coding salary is attractive, and certification programs are widely available online, offering flexibility and career growth potential.

Best Scientists Citing Jeffrey M. Jacobson

Trending Scientists

Recently Published Articles